Abstract

Percutaneous tibial nerve stimulation and sacral neuromodulation: an update

Gupta P1, Ehlert MJ, Sirls LT, Peters KM. Curr Urol Rep. 2015 Feb;16(2):479. doi: 10.1007/s11934-014-0479-1.
 
     
Author information

1Female Pelvic Medicine and Reconstructive Surgery, Beaumont Health System, 3535 W. 13 Mile Road, Ste. 438, Royal Oak, MI, 48073, USA, Priyanka.Gupta@beaumont.edu.

Abstract

Neuromodulation is an important treatment modality for a variety of pelvic floor disorders. Percutaneous tibial nerve stimulation (PTNS) and sacral neuromodulation (SNM) are currently the two approved methods for delivering this therapy. Percutaneous tibial nerve stimulation is a minimally invasive office-based procedure that has shown efficacy in the treatment of overactive bladder, fecal incontinence, and pelvic pain. It has the advantage of minimal side effects but is limited by the need for patients to make weekly office visits to receive the series of treatments. Sacral neuromodulation uses an implanted device that stimulates the S3 nerve root and can improve symptoms of overactive bladder, non-obstructive urinary retention, fecal incontinence, and pelvic pain. This paper will review the most recent literature regarding this topic and discuss their advantages and limitations and recent innovations in their use.

© Copyright 2013-2017 GI Health Foundation. All rights reserved.
This site is maintained as an educational resource for US healthcare providers only. Use of this website is governed by the GIHF terms of use and privacy statement.